Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Journal of Lipid Research
|
July 7, 2000
Plasma levels of remnant particles are determined in part by variation in the APOC3 gene insulin response element and the APOCI-APOE cluster
D M Waterworth, J A Hubacek, J Pitha, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society
|
June 8, 2021
Acute responses of hepatic fat content to consuming fat, glucose and fructose alone and in combination in non-obese non-diabetic individuals with non-alcoholic fatty liver disease
J Kovar, T Dusilova, P Sedivy, et al.
Journal of Medical Entomology
|
August 14, 2020
Developmental Plasticity of the Flesh Fly Blaesoxipha plinthopyga (Diptera: Sarcophagidae) on Different Substrates
Ahmed A El-Hefnawy, Faten F Abul Dahab, Abdelwahab A Ibrahim, et al.
Journal of Cardiovascular Pharmacology
|
October 1, 1993
Cardiovascular effects and hemodynamic mechanism of action of the novel, nonpeptidic renin inhibitor A-74273 in dogs
J L Wessale, S V Calzadilla, S A Boyd, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1993
Effects of high doses of A-74273, a novel nonpeptidic and orally bioavailable renin inhibitor
K M Verburg, J S Polakowski, P J Kovar, et al.
Medchemcomm
|
July 16, 2019
Controlling cellular distribution of drugs with permeability modifying moieties
Paul L Richardson, Violeta L Marin, Stormy L Koeniger, et al.
ACS Medicinal Chemistry Letters
|
June 18, 2021
Structure-Based Design of A-1293102, a Potent and Selective BCL-X<sub>L</sub> Inhibitor
Zhi-Fu Tao, Xilu Wang, Jun Chen, et al.
ACS Medicinal Chemistry Letters
|
July 16, 2021
Balancing Properties with Carboxylates: A Lead Optimization Campaign for Selective and Orally Active CDK9 Inhibitors
Yunsong Tong, Alan S Florjancic, Rick F Clark, et al.
Journal of Medicinal Chemistry
|
April 24, 2020
Discovery of <i>N</i>-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain
George S Sheppard, Le Wang, Steven D Fidanze, et al.
Journal of Medicinal Chemistry
|
February 14, 2015
Structure-guided design of a series of MCL-1 inhibitors with high affinity and selectivity
Milan Bruncko, Le Wang, George S Sheppard, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Journal of Lipid Research
|
July 7, 2000
Plasma levels of remnant particles are determined in part by variation in the APOC3 gene insulin response element and the APOCI-APOE cluster
D M Waterworth, J A Hubacek, J Pitha, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society
|
June 8, 2021
Acute responses of hepatic fat content to consuming fat, glucose and fructose alone and in combination in non-obese non-diabetic individuals with non-alcoholic fatty liver disease
J Kovar, T Dusilova, P Sedivy, et al.
Journal of Medical Entomology
|
August 14, 2020
Developmental Plasticity of the Flesh Fly Blaesoxipha plinthopyga (Diptera: Sarcophagidae) on Different Substrates
Ahmed A El-Hefnawy, Faten F Abul Dahab, Abdelwahab A Ibrahim, et al.
Journal of Cardiovascular Pharmacology
|
October 1, 1993
Cardiovascular effects and hemodynamic mechanism of action of the novel, nonpeptidic renin inhibitor A-74273 in dogs
J L Wessale, S V Calzadilla, S A Boyd, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1993
Effects of high doses of A-74273, a novel nonpeptidic and orally bioavailable renin inhibitor
K M Verburg, J S Polakowski, P J Kovar, et al.
Medchemcomm
|
July 16, 2019
Controlling cellular distribution of drugs with permeability modifying moieties
Paul L Richardson, Violeta L Marin, Stormy L Koeniger, et al.
ACS Medicinal Chemistry Letters
|
June 18, 2021
Structure-Based Design of A-1293102, a Potent and Selective BCL-X<sub>L</sub> Inhibitor
Zhi-Fu Tao, Xilu Wang, Jun Chen, et al.
ACS Medicinal Chemistry Letters
|
July 16, 2021
Balancing Properties with Carboxylates: A Lead Optimization Campaign for Selective and Orally Active CDK9 Inhibitors
Yunsong Tong, Alan S Florjancic, Rick F Clark, et al.
Journal of Medicinal Chemistry
|
April 24, 2020
Discovery of <i>N</i>-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain
George S Sheppard, Le Wang, Steven D Fidanze, et al.
Journal of Medicinal Chemistry
|
February 14, 2015
Structure-guided design of a series of MCL-1 inhibitors with high affinity and selectivity
Milan Bruncko, Le Wang, George S Sheppard, et al.
Page
of 4